These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
422 related items for PubMed ID: 19490966
1. High level virion production and surface antigen expression with 1.5 copies of hepatitis B viral genome. Dong Q, Liu Z, Chen Y, Chan CY, Lin MC, Kung HF, Chan HL, Sung JJ, He ML. J Virol Methods; 2009 Aug; 159(2):135-40. PubMed ID: 19490966 [Abstract] [Full Text] [Related]
2. Inhibitory effect of HMGN2 protein on human hepatitis B virus expression and replication in the HepG2.2.15 cell line. Feng Y, He F, Zhang P, Wu Q, Huang N, Tang H, Kong X, Li Y, Lu J, Chen Q, Wang B. Antiviral Res; 2009 Mar; 81(3):277-82. PubMed ID: 19150374 [Abstract] [Full Text] [Related]
3. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area. Yin J, Zhang H, Li C, Gao C, He Y, Zhai Y, Zhang P, Xu L, Tan X, Chen J, Cheng S, Schaefer S, Cao G. Carcinogenesis; 2008 Sep; 29(9):1685-91. PubMed ID: 18192693 [Abstract] [Full Text] [Related]
4. [An in vitro model of hepatitis B virus gene replication and expression in primary rat hepatocytes transfected with circular viral DNA]. Yao YQ, Zhang DF, Luo Y, Zhang DZ, Huang AL, Wang B, Zhou WP, Ren H, Guo SH. Zhonghua Gan Zang Bing Za Zhi; 2002 Aug; 10(4):275-8. PubMed ID: 12223138 [Abstract] [Full Text] [Related]
5. A hepatocellular carcinoma cell line producing mature hepatitis B viral particles. Fellig Y, Almogy G, Galun E, Ketzinel-Gilad M. Biochem Biophys Res Commun; 2004 Aug 20; 321(2):269-74. PubMed ID: 15358171 [Abstract] [Full Text] [Related]
6. Liver-derived cell lines QSG-7701 and HepG2 support different HBV replication patterns. Pan XB, Wei L, Chen HS, Liu F, Gao Y. Arch Virol; 2007 Aug 20; 152(6):1159-73. PubMed ID: 17308979 [Abstract] [Full Text] [Related]
7. Molecular characterization of a variant virus that caused de novo hepatitis B without elevation of hepatitis B surface antigen after chemotherapy with rituximab. Miyagawa M, Minami M, Fujii K, Sendo R, Mori K, Shimizu D, Nakajima T, Yasui K, Itoh Y, Taniwaki M, Okanoue T, Yoshikawa T. J Med Virol; 2008 Dec 20; 80(12):2069-78. PubMed ID: 19040281 [Abstract] [Full Text] [Related]
8. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells. Ren JL, Pan JS, Cheng T, Dong J, Lu YP, Huang SJ, Shi HX, Wang L, Lian YM. Chin J Dig Dis; 2006 Dec 20; 7(4):230-6. PubMed ID: 17054586 [Abstract] [Full Text] [Related]
9. [Study on the replication of Hepatitis B Virus in primary hepatocytes from heterogenous species]. Yao YQ, Zhang DF, Huang AL, Tang N, Wang B, Zhou WP, Ren H, Guo SH. Zhonghua Gan Zang Bing Za Zhi; 2004 Jan 20; 12(1):25-8. PubMed ID: 14761278 [Abstract] [Full Text] [Related]
10. Hepatitis B virus replication in human HepG2 cells mediated by hepatitis B virus recombinant baculovirus. Delaney WE, Isom HC. Hepatology; 1998 Oct 20; 28(4):1134-46. PubMed ID: 9755254 [Abstract] [Full Text] [Related]
11. [Effect of cell cycle on telomerase activity of hepatoma cells and its relationship with replication of hepatitis B virus]. Yan SN, Deng B, Gong ZJ. Ai Zheng; 2003 May 20; 22(5):504-7. PubMed ID: 12753712 [Abstract] [Full Text] [Related]
12. Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors. Ren S, Nassal M. J Virol; 2001 Feb 20; 75(3):1104-16. PubMed ID: 11152483 [Abstract] [Full Text] [Related]
13. A double-spliced defective hepatitis B virus genome derived from hepatocellular carcinoma tissue enhanced replication of full-length virus. Ma ZM, Lin X, Wang YX, Tian XC, Xie YH, Wen YM. J Med Virol; 2009 Feb 20; 81(2):230-7. PubMed ID: 19107969 [Abstract] [Full Text] [Related]
14. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell. Xin XM, Li GQ, Guan XR, Li D, Xu WZ, Jin YY, Gu HX. Hepatogastroenterology; 2008 Feb 20; 55(88):2178-83. PubMed ID: 19260501 [Abstract] [Full Text] [Related]
15. Deletion of integrated hepatitis B virus genome and cellular flanking sequences in hepatocellular carcinoma cells in BALB/c mice. Chang PC, Hu CP, Chen SH, Wang-Wuu S, Chang C. Hepatology; 1995 Jun 20; 21(6):1504-9. PubMed ID: 7768493 [Abstract] [Full Text] [Related]
16. Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210. Zhang GL, Li YX, Zheng SQ, Liu M, Li X, Tang H. Antiviral Res; 2010 Nov 20; 88(2):169-75. PubMed ID: 20728471 [Abstract] [Full Text] [Related]
17. Effects of cell cycle on telomerase activity and on hepatitis B virus replication in HepG2 2.2.15 cells. Huang YQ, Wang LW, Yan SN, Gong ZJ. Hepatobiliary Pancreat Dis Int; 2004 Nov 20; 3(4):543-7. PubMed ID: 15567742 [Abstract] [Full Text] [Related]
18. Full-length genomic analysis of hepatitis B virus isolates in a patient progressing from hepatitis to hepatocellular carcinoma. Lin X, Qian GS, Lu PX, Wu L, Wen YM. J Med Virol; 2001 Aug 20; 64(4):299-304. PubMed ID: 11468748 [Abstract] [Full Text] [Related]
19. Quantification of hepatitis B virus covalently closed circular DNA in patients with hepatocellular carcinoma. Wong DK, Yuen MF, Poon RT, Yuen JC, Fung J, Lai CL. J Hepatol; 2006 Oct 20; 45(4):553-9. PubMed ID: 16904225 [Abstract] [Full Text] [Related]
20. Antisense oligonucleotides targeted against asialoglycoprotein receptor 1 block human hepatitis B virus replication. Yang J, Bo XC, Ding XR, Dai JM, Zhang ML, Wang XH, Wang SQ. J Viral Hepat; 2006 Mar 20; 13(3):158-65. PubMed ID: 16475991 [Abstract] [Full Text] [Related] Page: [Next] [New Search]